Cargando…
Gene Therapy With Regulatory T Cells: A Beneficial Alliance
Gene therapy aims to replace a defective or a deficient protein at therapeutic or curative levels. Improved vector designs have enhanced safety, efficacy, and delivery, with potential for lasting treatment. However, innate and adaptive immune responses to the viral vector and transgene product remai...
Autores principales: | Biswas, Moanaro, Kumar, Sandeep R. P., Terhorst, Cox, Herzog, Roland W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868074/ https://www.ncbi.nlm.nih.gov/pubmed/29616042 http://dx.doi.org/10.3389/fimmu.2018.00554 |
Ejemplares similares
-
Treg: tolerance vs immunity
por: Biswas, Moanaro, et al.
Publicado: (2015) -
Reprogrammed CD4(+) T Cells That Express FoxP3(+) Control Inhibitory Antibody Formation in Hemophilia A Mice
por: Herzog, Roland W., et al.
Publicado: (2019) -
Distinct functions and transcriptional signatures in orally induced regulatory T cell populations
por: Biswas, Moanaro, et al.
Publicado: (2023) -
Innovative Approaches for Immune Tolerance to Factor VIII in the Treatment of Hemophilia A
por: Sherman, Alexandra, et al.
Publicado: (2017) -
Ex vivo expanded autologous polyclonal regulatory T cells suppress inhibitor formation in hemophilia
por: Sarkar, Debalina, et al.
Publicado: (2014)